Abstract

With the incidence reports of pancreatic cancer increasing every year, research over the last several decades has been focused on the means to achieve early diagnosis in patients that are at a high risk of developing the malignancy. This review covers current strategies for managing pancreatic cancer and further discusses efforts in understanding the role of early onset symptoms leading to tumor progression. Recent investigations in this discussion include type 3c diabetes, selected biomarkers and pathways related to pancreatic intraepithelial neoplasia lesions, drug resistance, and advances in nanomedicine which may provide significant solutions for improving early detection and treatments in future medicine.

Original languageEnglish (US)
Pages (from-to)14717-14725
Number of pages9
JournalWorld journal of gastroenterology
Volume20
Issue number40
DOIs
StatePublished - Oct 28 2014

Fingerprint

Pancreatic Neoplasms
Nanomedicine
Neoplasms
Drug Resistance
Early Diagnosis
Biomarkers
Medicine
Incidence
Research
Therapeutics

All Science Journal Classification (ASJC) codes

  • Gastroenterology

Cite this

Loc, Welley S. ; Smith, Jill P. ; Matters, Gail ; Kester, Mark ; Adair, James Hansell. / Novel strategies for managing pancreatic cancer. In: World journal of gastroenterology. 2014 ; Vol. 20, No. 40. pp. 14717-14725.
@article{b0da5bd21a0e43c281d1c5eae0dfc341,
title = "Novel strategies for managing pancreatic cancer",
abstract = "With the incidence reports of pancreatic cancer increasing every year, research over the last several decades has been focused on the means to achieve early diagnosis in patients that are at a high risk of developing the malignancy. This review covers current strategies for managing pancreatic cancer and further discusses efforts in understanding the role of early onset symptoms leading to tumor progression. Recent investigations in this discussion include type 3c diabetes, selected biomarkers and pathways related to pancreatic intraepithelial neoplasia lesions, drug resistance, and advances in nanomedicine which may provide significant solutions for improving early detection and treatments in future medicine.",
author = "Loc, {Welley S.} and Smith, {Jill P.} and Gail Matters and Mark Kester and Adair, {James Hansell}",
year = "2014",
month = "10",
day = "28",
doi = "10.3748/wjg.v20.i40.14717",
language = "English (US)",
volume = "20",
pages = "14717--14725",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "40",

}

Novel strategies for managing pancreatic cancer. / Loc, Welley S.; Smith, Jill P.; Matters, Gail; Kester, Mark; Adair, James Hansell.

In: World journal of gastroenterology, Vol. 20, No. 40, 28.10.2014, p. 14717-14725.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Novel strategies for managing pancreatic cancer

AU - Loc, Welley S.

AU - Smith, Jill P.

AU - Matters, Gail

AU - Kester, Mark

AU - Adair, James Hansell

PY - 2014/10/28

Y1 - 2014/10/28

N2 - With the incidence reports of pancreatic cancer increasing every year, research over the last several decades has been focused on the means to achieve early diagnosis in patients that are at a high risk of developing the malignancy. This review covers current strategies for managing pancreatic cancer and further discusses efforts in understanding the role of early onset symptoms leading to tumor progression. Recent investigations in this discussion include type 3c diabetes, selected biomarkers and pathways related to pancreatic intraepithelial neoplasia lesions, drug resistance, and advances in nanomedicine which may provide significant solutions for improving early detection and treatments in future medicine.

AB - With the incidence reports of pancreatic cancer increasing every year, research over the last several decades has been focused on the means to achieve early diagnosis in patients that are at a high risk of developing the malignancy. This review covers current strategies for managing pancreatic cancer and further discusses efforts in understanding the role of early onset symptoms leading to tumor progression. Recent investigations in this discussion include type 3c diabetes, selected biomarkers and pathways related to pancreatic intraepithelial neoplasia lesions, drug resistance, and advances in nanomedicine which may provide significant solutions for improving early detection and treatments in future medicine.

UR - http://www.scopus.com/inward/record.url?scp=84910633425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84910633425&partnerID=8YFLogxK

U2 - 10.3748/wjg.v20.i40.14717

DO - 10.3748/wjg.v20.i40.14717

M3 - Review article

VL - 20

SP - 14717

EP - 14725

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 40

ER -